CNC Centene Corporation Common Stock
NYSE · Health Care · Auf SEC EDGAR ansehen ↗ Schließen Okt 6, 2026 10-K/10-Q Jul 28, 2026CNC Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
CNC Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
| Ex-Datum | Split | Typ |
|---|---|---|
| 7. Februar 2019 | 2-for-1 | Vorwärts |
| 20. Februar 2015 | 2-for-1 | Vorwärts |
| 20. Dezember 2004 | 2-for-1 | Vorwärts |
| 14. Juli 2003 | 3-for-2 | Vorwärts |
Über Centene Corporation Common Stock Unternehmensübersicht von Wikipedia
Die Centene Corporation ist ein US-amerikanischer Anbieter von Versicherungsleistungen im Gesundheitswesen. Das Unternehmen spezialisiert sich auf Medicaid- und Medicare-Leistungen und kooperiert dabei mit den Regierungen der Bundesstaaten sowie der US-Bundesregierung. Nach eigenen Angaben betreut Centene über 13 Millionen Medicaid-Mitglieder und mehr als 1,1 Millionen Medicare-Berechtigte. Darüber hinaus bietet das Unternehmen Gesundheitsdienstleistungen für Gefängnisinsassen an.
Centene wurde 1984 unter dem Namen Family Hospital Physician Associates als gemeinnützige Organisation zur Umsetzung eines Medicaid-Plans gegründet. Die ehemalige Krankenhaus-Buchhalterin Elizabeth Brinn leitete das Unternehmen anfangs aus dem Keller eines Krankenhauses in Milwaukee. 1995 begann das Unternehmen mit der Expansion nach Indiana, 1997 erfolgte die Umbenennung in Centene und die Verlegung des Hauptsitzes nach St. Louis, Missouri. 2001 ging das Unternehmen mit einem Jahresumsatz von 327 Millionen US-Dollar und 235.000 Kunden an die Börse. Bereits 2004 überschritt der Umsatz erstmals die Marke von 1 Milliarde US-Dollar. In den Folgejahren wuchs Centene durch zahlreiche Übernahmen anderer Versicherungsunternehmen.
Centene zählt zu den umsatzstärksten Unternehmen der USA und belegte 2023 Rang 60 der Fortune Global 500.
## Kritik und Kontroversen
Ab 2021 wurde bekannt, dass Centene mehreren Bundesstaaten im Rahmen von Medicaid überhöhte Rechnungen für verschreibungspflichtige Medikamente ausgestellt hatte. Die Streitigkeiten sollen über Rückzahlungen Centenes beigelegt worden sein, über deren volle Höhe die Öffentlichkeit allerdings nicht informiert wurde. Alleine dem Staate Florida soll durch überhöhte Rechnungen ein Schaden über 67 Millionen Dollar entstanden sein. Es wurde bekannt, dass 10 Millionen Dollar des Rückzahlungsbetrags statt direkt an den Staat, an die „Hope Florida Foundation“ überwiesen wurden. Dabei handelt es sich um eine Wohltätigkeitsorganisation, die 2021 von Casey DeSantis gegründet worden war. Es besteht der Verdacht, dass Gelder hieraus mittelbar für politische Zwecke durch Ron DeSantis und die Republikanische Partei genutzt wurden.
== Einzelnachweise ==
Quelle: Wikipedia, CC BY-SA 4.0 · Auf Wikipedia ansehen ↗
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | CNC | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E (TTM) | -6.25-Jahres-Durchschnitt ≈19.5 | ≈19.5 | · | · | |
| P/S (TTM) | 0.25-Jahres-Durchschnitt ≈0.2 | ≈0.2 | 0.7 | Unterbewertet | |
| K/B (MRQ) | 1.45-Jahres-Durchschnitt ≈1.5 | ≈1.5 | 3.9 | Unterbewertet | |
| EV / EBITDA | -4.95-Jahres-Durchschnitt ≈17.4 | ≈17.4 | · | · | |
| Kurs / FCF (TTM) | 3.65-Jahres-Durchschnitt ≈-5.6 | ≈-5.6 | · | · | |
| Kurs / Cashflow (TTM) | 3.35-Jahres-Durchschnitt ≈44.5 | ≈44.5 | 15.6 | Unterbewertet | |
| EV / Umsatz (TTM) | 0.15-Jahres-Durchschnitt ≈0.3 | ≈0.3 | · | · | |
| EV / FCF (TTM) | 2.35-Jahres-Durchschnitt ≈-6.1 | ≈-6.1 | · | · | |
| Kurs / Materieller Buchwert (MRQ) | 1.75-Jahres-Durchschnitt ≈10.4 | ≈10.4 | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | CNC | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Bruttogewinnmarge (TTM) | 8.0%5-Jahres-Durchschnitt ≈9.7% | ≈9.7% | 25.0% | Schwach | |
| Betriebsgewinnmarge (TTM) | -2.8%5-Jahres-Durchschnitt ≈0.45% | ≈0.45% | 3.5% | Schwach | |
| EBITDA Margin (EBITDA-Marge) | -3.9%5-Jahres-Durchschnitt ≈0.45% | ≈0.45% | 3.7% | Schwach | |
| Vorgewinnmarge (TTM) | -2.3%5-Jahres-Durchschnitt ≈0.86% | ≈0.86% | 2.8% | Schwach | |
| Nettogewinnmarge (TTM) | -2.5%5-Jahres-Durchschnitt ≈0.45% | ≈0.45% | 2.9% | Schwach | |
| ROA (TTM) | -6.0%5-Jahres-Durchschnitt ≈0.46% | ≈0.46% | 3.0% | Schwach | |
| ROE (TTM) | -20.4%5-Jahres-Durchschnitt ≈0.91% | ≈0.91% | 10.1% | Schwach | |
| ROIC | -20.2%5-Jahres-Durchschnitt ≈-0.99% | ≈-0.99% | 8.0% | Schwach |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | CNC | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital (MRQ) | 0.75-Jahres-Durchschnitt ≈0.7 | ≈0.7 | 0.7 | Hohe Verschuldung | |
| Liquiditätsgrad (MRQ) | 1.15-Jahres-Durchschnitt ≈1.1 | ≈1.1 | 1.7 | Geringe Liquidität | |
| Quick Ratio | 0.65-Jahres-Durchschnitt ≈0.5 | ≈0.5 | 1.3 | Geringe Liquidität | |
| Langfristige Schulden / Eigenkapital (MRQ) | 0.75-Jahres-Durchschnitt ≈0.7 | ≈0.7 | 0.7 | Hohe Verschuldung |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
| Kennzahl | 5-Jahres-Trend | CNC | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue YoY (Umsatz YoY) | 19.4%5-Jahres-Durchschnitt ≈12.0% | ≈12.0% | · | · | |
| Revenue CAGR 3Y (Umsatz CAGR 3J) | 10.4%5-Jahres-Durchschnitt ≈10.3% | ≈10.3% | · | · | |
| Revenue CAGR 5Y (Umsatz CAGR 5J) | 11.9% | · | · | · | |
| EPS YoY (EPS VjV) | 27.5%5-Jahres-Durchschnitt ≈32.6% | ≈32.6% | · | · | |
| Net Income YoY (Nettogewinn YoY) | 22.3%5-Jahres-Durchschnitt ≈27.7% | ≈27.7% | · | · | |
| EPS CAGR 3Y (EPS CAGR 3J) | 40.4% | · | · | · | |
| Net Income CAGR 3Y (Nettoergebnis CAGR 3J) | 34.9% | · | · | · |
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | CNC | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Asset Turnover (Umsatz / Vermögenswerte) | 2.45-Jahres-Durchschnitt ≈2.0 | ≈2.0 | 2.4 | Im Einklang | |
| Revenue / Employee (Umsatz / Mitarbeiter) | ≈$3.2M | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Jul 28, 2026 | $2.51 | $1.10 | 129.0% |
| 31. März 2026 | $3.37 | $2.15 | 56.4% | |
| 31. Dezember 2025 | $-1.19 | $-1.24 | 3.7% | |
| 30. September 2025 | $0.50 | $-0.14 | 454.9% | |
| 30. Juni 2025 | $-0.16 | $0.87 | -118.5% | |
| 31. März 2025 | $2.90 | $2.57 | 12.9% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $194.78B | $163.07B | $154.00B | $144.55B | $125.98B | $111.11B | $74.64B | $60.12B | $48.38B | $40.61B | $22.76B | $16.56B | |
| Cost of Revenue | $2.67B | $2.73B | $3.56B | $7.03B | $4.89B | $3.30B | $2.46B | $2.39B | $1.85B | $1.86B | $1.62B | $1.28B | |
| Gross Profit | $14.21B | $17.07B | $17.64B | $16.92B | $14.49B | · | · | · | · | · | · | · | |
| SG&A Expense | $12.90B | $12.40B | $12.56B | $11.59B | $9.60B | $9.38B | $6.53B | $6.04B | $4.45B | $3.67B | $1.80B | $1.30B | |
| Operating Expenses | $202.40B | $159.90B | $151.07B | $143.23B | $124.20B | $108.03B | $72.86B | $58.66B | $47.18B | $39.34B | $22.05B | $16.10B | |
| Operating Income | $-7.62B | $3.17B | $2.93B | $1.32B | $1.78B | $3.08B | $1.78B | $1.46B | $1.20B | $1.26B | $705M | $464M | |
| Interest Expense | · | · | $725M | $665M | $665M | $728M | $412M | $343M | $255M | $217M | $43M | $35M | |
| Other Non-op | $895M | $1.08B | $668M | $644M | · | · | · | · | · | · | · | · | |
| Pretax Income | $-6.73B | $4.26B | $3.60B | $1.96B | $1.81B | $2.77B | $1.78B | $1.37B | $1.13B | $1.16B | $697M | $457M | |
| Income Tax | $-51M | $963M | $899M | $760M | $477M | $979M | $473M | $474M | $326M | $599M | $339M | $196M | |
| Net Income | $-6.67B | $3.31B | $2.70B | $1.20B | $1.35B | $1.81B | $1.32B | $900M | $828M | $562M | $355M | $271M | |
| EPS (Basic) | $-13.53 | $6.33 | $4.97 | $2.09 | $2.31 | $3.17 | $3.19 | $2.31 | $2.40 | $1.76 | $2.98 | $2.33 | |
| EPS (Diluted) | $-13.53 | $6.31 | $4.95 | $2.07 | $2.28 | $3.12 | $3.14 | $2.26 | $2.34 | $1.71 | $2.88 | $2.25 | |
| Shares (Basic) | 493,116,000 | 521,790,000 | 543,319,000 | 575,191,000 | 582,832,000 | 570,722,000 | 413,487,000 | 390,248,000 | 344,853,000 | 319,135,000 | 119,101,000 | 116,345,764 | |
| Shares (Diluted) | 493,116,000 | 523,744,000 | 545,704,000 | 582,040,000 | 590,516,000 | 579,135,000 | 420,409,000 | 398,506,000 | 353,404,000 | 327,951,000 | 123,066,000 | 120,360,212 | |
| EBITDA | $-7.62B | $3.17B | $2.93B | $1.32B | $1.78B | $3.08B | $1.78B | $1.46B | $1.20B | $1.26B | $705M | $464M |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $17.89B | $14.06B | $17.19B | $12.07B | $13.12B | $10.80B | $12.12B | $5.34B | $4.07B | $3.93B | $1.76B | $1.61B | |
| Short-term Investments | $2.43B | $2.62B | $2.46B | $2.32B | $1.54B | $1.58B | $863M | $722M | $531M | $505M | $176M | $177M | |
| Other Current Assets | $1.95B | $1.60B | $5.57B | $2.46B | $1.60B | $1.32B | $1.09B | $784M | $687M | $715M | $390M | $252M | |
| Current Assets | $40.37B | $38.00B | $40.76B | $30.13B | $28.50B | $23.39B | $20.32B | $12.00B | $8.70B | $8.37B | $3.60B | $2.95B | |
| PP&E (Net) | $2.04B | $2.07B | $2.02B | $2.43B | $3.39B | $2.77B | $2.12B | $1.71B | $1.10B | $797M | $518M | $445M | |
| PP&E (Gross) | $4.27B | $4.87B | $4.42B | $4.50B | $5.29B | $4.25B | $3.22B | $2.51B | $1.69B | $1.24B | $869M | $733M | |
| Accum. Depreciation | $2.23B | $2.80B | $2.40B | $2.07B | $1.90B | $1.48B | $1.10B | $800M | $590M | $442M | $351M | $288M | |
| Goodwill | $10.84B | $17.56B | $17.56B | $18.81B | $19.77B | $18.65B | $6.86B | $7.01B | $4.75B | $4.71B | $842M | $754M | |
| Intangibles | $4.53B | $5.41B | $6.10B | $6.91B | $7.82B | $8.39B | $2.06B | $2.24B | $1.40B | $1.54B | $155M | $120M | |
| Other Non-current Assets | $528M | $593M | $535M | $2.69B | $3.78B | $1.60B | $1.25B | $527M | $454M | $95M | $177M | $174M | |
| Total Assets | $76.75B | $82.44B | $84.64B | $76.87B | $78.38B | $68.72B | $40.99B | $30.90B | $21.86B | $20.20B | $7.34B | $5.82B | |
| Accounts Payable | $13.80B | $13.17B | $16.42B | $9.53B | $8.49B | $7.07B | $4.16B | $4.05B | $4.17B | $3.76B | $976M | $768M | |
| Current Liabilities | $36.72B | $34.26B | $36.72B | $28.46B | $25.77B | $21.59B | $12.93B | $11.97B | $9.33B | $8.62B | $3.63B | $2.90B | |
| Capital Leases | $615M | $738M | $880M | $3.13B | $3.62B | $1.33B | $622M | · | · | · | · | · | |
| Deferred Tax | $833M | $684M | $641M | $615M | $1.41B | $1.53B | $189M | · | · | · | · | · | |
| Other Non-current Liabilities | $1.79B | $2.57B | $3.62B | $5.62B | $5.61B | $2.96B | $1.54B | $1.26B | $952M | $869M | $170M | $159M | |
| Total Liabilities | $56.69B | $55.94B | $58.69B | $52.63B | $51.35B | $42.76B | $28.30B | $19.88B | $14.98B | $14.14B | $5.01B | $3.93B | |
| Long-term Debt | $17.49B | $18.64B | $17.96B | $18.18B | $19.03B | $16.88B | $13.86B | $6.85B | $4.83B | $4.78B | $1.22B | $878M | |
| Total Debt | $17.40B | $18.53B | $17.83B | $18.02B | $18.84B | $16.78B | $13.73B | $6.69B | $4.70B | $4.66B | $1.22B | $893M | |
| Common Stock | $1M | $1M | $1M | $1M | $1M | $1M | $0 | $0 | $0 | $0 | $0 | $0 | |
| Retained Earnings | $8.67B | $15.35B | $12.04B | $9.34B | $8.14B | $6.79B | $4.98B | $3.66B | $2.75B | $1.92B | $1.36B | $1.00B | |
| Treasury Stock | $9.44B | $9.00B | $5.86B | $4.21B | $1.09B | $816M | $214M | $139M | $244M | $179M | $147M | $98M | |
| AOCI | $-58M | $-504M | $-652M | $-1.13B | $77M | $337M | $134M | $-56M | $-3M | $-36M | $-10M | $-1M | |
| Stockholders' Equity | $19.95B | $26.41B | $25.84B | $24.06B | $26.80B | $25.77B | $12.55B | $10.92B | $6.85B | $5.89B | $2.16B | $1.74B | |
| Liabilities + Equity | $76.75B | $82.44B | $84.64B | $76.87B | $78.38B | $68.72B | $40.99B | $30.90B | $21.86B | $20.20B | $7.34B | $5.82B | |
| Shares Outstanding | 491,757,000 | 620,195,000 | 615,291,000 | 607,847,000 | 602,704,000 | 598,249,000 | 421,508,000 | 417,695,000 | 360,758,000 | 356,268,000 | 253,710,000 | 124,275,000 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $1.27B | $1.24B | $1.29B | $1.43B | $1.33B | $1.26B | $643M | $495M | $361M | $278M | $111M | $89M | |
| Stock-based Comp | $204M | $212M | $216M | $234M | $203M | $281M | $177M | $145M | $135M | $148M | $71M | $48M | |
| Deferred Tax | $-60M | $13M | $-78M | $-631M | $-132M | $-51M | $55M | $-129M | $-108M | $92M | $-17M | $-42M | |
| Amort. of Intangibles | $685M | $692M | $718M | $817M | $770M | $719M | $258M | $211M | $156M | $147M | $24M | $16M | |
| Operating Cash Flow | $5.09B | $154M | $8.05B | $6.26B | $4.21B | $5.50B | $1.48B | $1.23B | $1.49B | $1.85B | $658M | $1.22B | |
| CapEx | $767M | $644M | $799M | $1.00B | $910M | $869M | $730M | $675M | $422M | $306M | $150M | $103M | |
| Investing Cash Flow | $472M | $-1.05B | $-1.19B | $-2.92B | $-3.30B | $-6.96B | $-1.53B | $-4.58B | $-1.25B | $-2.47B | $-813M | $-848M | |
| Debt Issued | $750M | $1.30B | $2.33B | $360M | $9.27B | $5.11B | $24.72B | $6.08B | $1.40B | $8.95B | $1.93B | $1.88B | |
| Net Debt Issued | $-1.15B | $678M | $19M | $-1.13B | $1.83B | $1.04B | $6.92B | $1.99B | $47M | $2.87B | $342M | $201M | |
| Stock Issued | $37M | $46M | $44M | $70M | $35M | $28M | $0 | $2.78B | $0 | $0 | · | · | |
| Stock Repurchased | $475M | $3.12B | $1.63B | $3.10B | $297M | $626M | $75M | $71M | $65M | $63M | $53M | $29M | |
| Net Stock Activity | $-438M | $-3.08B | $-1.59B | $-3.03B | $-297M | $-626M | $-75M | $2.71B | $-65M | $-63M | $-53M | $-29M | |
| Financing Cash Flow | $-1.62B | $-2.41B | $-1.66B | $-4.20B | $1.36B | $260M | $6.83B | $4.61B | $-82M | $2.72B | $305M | $198M | |
| Net Change in Cash | $3.94B | $-3.30B | $5.17B | $-868M | $2.26B | $-1.17B | $6.78B | $1.26B | $153M | $2.10B | $150M | $572M | |
| Taxes Paid | $448M | $1.00B | $887M | $1.20B | $678M | $1.19B | $612M | $448M | $496M | $556M | $328M | $237M | |
| Free Cash Flow | $4.32B | $-490M | $7.25B | $5.26B | $3.29B | $4.63B | $753M | $559M | $1.07B | $1.54B | $508M | $1.12B | |
| Levered FCF | · | · | $6.71B | $4.85B | $2.80B | $4.16B | $450M | $335M | $885M | $1.44B | $486M | $1.10B |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 7.3% | 10.5% | 11.5% | · | · | · | · | · | · | · | · | · | |
| Operating Margin | -3.9% | 1.9% | 1.9% | 0.91% | 1.4% | 2.8% | 2.4% | 2.4% | 2.5% | 3.1% | 3.1% | 2.8% | |
| Net Margin | -3.4% | 2.0% | 1.8% | 0.83% | 1.1% | 1.6% | 1.8% | 1.5% | 1.7% | 1.4% | 1.6% | 1.6% | |
| Pretax Margin | -3.5% | 2.6% | 2.3% | 1.4% | 1.4% | 2.5% | 2.4% | 2.3% | 2.3% | 2.9% | 3.1% | 2.8% | |
| EBITDA Margin | -3.9% | 1.9% | 1.9% | 0.91% | 1.4% | 2.8% | 2.4% | 2.4% | 2.5% | 3.1% | 3.1% | 2.8% | |
| ROA | -8.4% | 4.0% | 3.4% | 1.6% | 1.8% | 3.3% | 3.7% | 3.4% | 3.9% | 4.1% | 5.4% | 5.8% | |
| ROE | -28.8% | 12.7% | 10.8% | 4.7% | 5.1% | 9.4% | 11.3% | 10.1% | 13.0% | 14.0% | 18.2% | 18.2% | |
| ROIC | -20.2% | 5.5% | 5.0% | 1.9% | 2.9% | 4.7% | 5.0% | 5.4% | 7.4% | 5.8% | 10.7% | 10.1% |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.6 | 1.0 | 0.9 | 1.0 | 1.0 | 1.0 | |
| Quick Ratio | 0.6 | 0.5 | 0.5 | 0.5 | 0.6 | 0.6 | 1.0 | 0.5 | 0.5 | 0.5 | 0.5 | 0.6 | |
| Debt / Equity | 0.9 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 1.1 | 0.6 | 0.7 | 0.8 | 0.6 | 0.5 | |
| LT Debt / Equity | 0.9 | 0.7 | 0.7 | 0.7 | 0.7 | 0.6 | 1.1 | 0.6 | 0.7 | 0.8 | 0.6 | 0.5 | |
| Interest Coverage | · | · | 4.0 | 2.0 | 2.7 | 4.2 | 4.3 | 4.3 | 4.7 | 5.8 | 16.4 | 13.3 |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 2.4 | 2.0 | 1.9 | 1.9 | 1.7 | 2.0 | 2.1 | 2.3 | 2.3 | 2.9 | 3.5 | 3.5 |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $40.57 | $53.26 | $48.35 | $43.68 | $46.00 | $44.32 | $30.24 | $26.47 | $39.50 | $34.29 | $17.92 | $14.73 | |
| Revenue / Share | $394.99 | $311.36 | $282.20 | $248.35 | $213.34 | $191.86 | $177.54 | $150.85 | $273.81 | $247.64 | $184.94 | $137.59 | |
| Cash Flow / Share | $10.32 | $0.29 | $14.76 | $10.76 | $7.12 | $9.50 | $3.53 | $3.10 | $8.43 | $11.29 | $5.35 | $10.16 | |
| Cash / Share | $36.38 | $28.36 | $32.17 | $21.92 | $22.52 | $18.57 | $29.21 | $12.95 | $23.48 | $22.86 | $14.62 | $13.05 | |
| EPS (TTM) | $-13.53 | $6.31 | $4.95 | $2.07 | $2.28 | $3.12 | $3.14 | $2.26 | $2.34 | $1.71 | $2.88 | $2.25 |
Wachstumsraten
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 19.4% | 5.9% | 6.5% | 14.7% | 13.4% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 10.4% | 9.0% | 11.5% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 11.9% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | · | 27.5% | 139.1% | -9.2% | -26.9% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | · | 40.4% | 16.6% | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | · | 22.3% | 124.8% | -10.8% | -25.5% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | · | 34.9% | 14.3% | · | · | · | · | · | · | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $194.78B | $163.07B | $154.00B | $144.55B | $125.98B | $111.11B | $74.64B | $60.12B | $48.38B | $40.61B | $22.76B | $16.56B | |
| Net Income TTM | $-6.67B | $3.31B | $2.70B | $1.20B | $1.35B | $1.81B | $1.32B | $900M | $828M | $562M | $355M | $271M | |
| Market Cap | $20.24B | $30.04B | $39.66B | $45.17B | $48.00B | $34.91B | $26.09B | $23.78B | $8.75B | $4.86B | $3.96B | $3.07B | |
| Enterprise Value | $17.32B | $31.89B | $37.84B | $48.79B | $52.18B | $39.31B | $26.83B | $24.40B | $8.84B | $5.08B | $3.24B | $2.24B | |
| P/E | -3.0 | 9.6 | 15.0 | 39.6 | 36.1 | 19.2 | 20.0 | 25.5 | 21.6 | 16.5 | 11.4 | 11.5 | |
| P/S | 0.1 | 0.2 | 0.3 | 0.3 | 0.4 | 0.3 | 0.3 | 0.4 | 0.2 | 0.1 | 0.2 | 0.2 | |
| P/B | 1.0 | 1.1 | 1.5 | 1.9 | 1.8 | 1.4 | 2.1 | 2.2 | 1.3 | 0.8 | 1.8 | 1.8 | |
| P / Tangible Book | 4.4 | 8.7 | 18.2 | · | · | · | · | · | · | · | · | · | |
| P / Cash Flow | 4.0 | 195.1 | 4.9 | 7.2 | 11.4 | 6.3 | 17.6 | 19.3 | 5.9 | 2.6 | 6.0 | 2.5 | |
| P / FCF | 4.7 | -61.3 | 5.5 | 8.6 | 14.6 | 7.5 | 34.7 | 42.5 | 8.2 | 3.1 | 7.8 | 2.7 | |
| EV / EBITDA | -2.3 | 10.0 | 12.9 | 37.0 | 29.2 | 12.8 | 15.1 | 16.7 | 7.4 | 4.0 | 4.6 | 4.8 | |
| EV / FCF | 4.0 | -65.1 | 5.2 | 9.3 | 15.8 | 8.5 | 35.6 | 43.7 | 8.3 | 3.3 | 6.4 | 2.0 | |
| EV / Revenue | 0.1 | 0.2 | 0.2 | 0.3 | 0.4 | 0.4 | 0.4 | 0.4 | 0.2 | 0.1 | 0.1 | 0.1 | |
| Earnings Yield | -32.9% | 10.4% | 6.7% | 2.5% | 2.8% | 5.2% | 5.0% | 3.9% | 4.6% | 6.0% | 8.8% | 8.7% |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $53.58B | $49.94B | $49.73B | $49.69B | $48.74B | $46.62B | $40.80B | $42.02B | $39.84B | $40.41B | $39.46B | $38.04B | $37.61B | $38.89B | $35.56B | $35.87B | |
| Cost of Revenue | $729M | $702M | $680M | $651M | $641M | $698M | $688M | $692M | $680M | $669M | $961M | $856M | $877M | $870M | $1.37B | $1.57B | |
| Gross Profit | $4.62B | $5.65B | $2.56B | $3.35B | $3.02B | $5.29B | $3.80B | $4.01B | $4.53B | $4.74B | $3.74B | $4.63B | $4.61B | $4.65B | $3.91B | $4.04B | |
| SG&A Expense | $3.10B | $3.40B | $3.37B | $3.15B | $3.04B | $3.35B | $3.23B | $3.06B | $2.89B | $3.22B | $3.49B | $3.05B | $3.02B | $3.01B | $3.20B | $2.85B | |
| Operating Expenses | $52.38B | $48.08B | $51.47B | $56.64B | $49.20B | $45.09B | $40.63B | $41.36B | $38.61B | $39.30B | $39.65B | $37.31B | $36.44B | $37.67B | $35.84B | $35.39B | |
| Operating Income | $1.20B | $1.86B | $-1.75B | $-6.95B | $-458M | $1.53B | $175M | $665M | $1.23B | $1.11B | $-194M | $735M | $1.17B | $1.22B | $-282M | $476M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $178M | · | $181M | $181M | $180M | · | $169M | |
| Other Non-op | $288M | $238M | $202M | $280M | $201M | $212M | $172M | $256M | $287M | $367M | · | · | · | · | · | · | |
| Pretax Income | $1.49B | $2.10B | $-1.54B | $-6.67B | $-257M | $1.75B | $347M | $921M | $1.52B | $1.47B | $24M | $768M | $1.42B | $1.39B | $41M | $1.01B | |
| Income Tax | $399M | $560M | $-443M | $-42M | $2M | $432M | $67M | $211M | $370M | $315M | $-15M | $293M | $360M | $261M | $260M | $269M | |
| Net Income | $1.09B | $1.54B | $-1.10B | $-6.63B | $-253M | $1.31B | $283M | $713M | $1.15B | $1.16B | $45M | $469M | $1.06B | $1.13B | $-213M | $738M | |
| EPS (Basic) | $2.21 | $3.13 | $-2.16 | $-13.50 | $-0.51 | $2.64 | $0.63 | $1.37 | $2.16 | $2.17 | $0.12 | $0.87 | $1.93 | $2.05 | $-0.37 | $1.29 | |
| EPS (Diluted) | $2.19 | $3.11 | $-2.15 | $-13.50 | $-0.51 | $2.63 | $0.63 | $1.36 | $2.16 | $2.16 | $0.12 | $0.87 | $1.92 | $2.04 | $-0.35 | $1.27 | |
| Shares (Basic) | 493,819,000 | 492,069,000 | · | 491,141,000 | 493,548,000 | 496,214,000 | · | 521,965,000 | 529,602,000 | 535,109,000 | · | 539,535,000 | 548,932,000 | 550,779,000 | · | 573,961,000 | |
| Shares (Diluted) | 497,637,000 | 495,591,000 | · | 491,141,000 | 493,548,000 | 498,180,000 | · | 523,542,000 | 530,755,000 | 538,060,000 | · | 541,270,000 | 550,308,000 | 553,845,000 | · | 580,607,000 | |
| EBITDA | $1.20B | $1.86B | · | $-6.95B | $-458M | $1.53B | · | $665M | $1.23B | $1.11B | · | $735M | $1.17B | $1.22B | · | $476M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $24.15B | $21.26B | $17.89B | $17.06B | $14.51B | $14.81B | $14.06B | $14.58B | $17.61B | $17.59B | $17.19B | $18.19B | $17.17B | $15.85B | $12.07B | $14.99B | |
| Short-term Investments | $2.91B | $2.48B | $2.43B | $2.18B | $2.77B | $2.47B | $2.62B | $2.99B | $2.61B | $2.08B | · | $2.24B | $2.21B | $2.13B | · | $2.19B | |
| Other Current Assets | $1.55B | $1.82B | $1.95B | $1.72B | $1.56B | $1.56B | $1.60B | $1.56B | $1.60B | $1.96B | · | $5.47B | $1.88B | $1.81B | · | $2.33B | |
| Current Assets | $46.69B | $44.99B | $40.37B | $44.06B | $40.39B | $41.29B | $38.00B | $37.41B | $38.41B | $38.45B | · | $41.41B | $34.87B | $35.01B | · | $33.27B | |
| PP&E (Net) | $2.13B | $2.09B | $2.04B | $2.16B | $2.12B | $2.04B | $2.07B | $2.04B | $2.04B | $1.99B | · | $2.00B | $2.42B | $2.48B | · | $2.48B | |
| PP&E (Gross) | · | · | $4.27B | · | · | · | $4.87B | · | · | · | · | · | · | · | · | $4.54B | |
| Accum. Depreciation | · | · | $2.23B | · | · | · | $2.80B | · | · | · | · | · | · | · | · | $2.06B | |
| Goodwill | $10.84B | $10.84B | $10.84B | $10.84B | $17.56B | $17.56B | $17.56B | $17.56B | $17.56B | $17.56B | $17.56B | $17.56B | $18.72B | $18.84B | $18.81B | $20.04B | |
| Intangibles | $4.20B | $4.36B | $4.53B | $4.84B | $5.01B | $5.24B | $5.41B | $5.58B | $5.75B | $5.93B | · | $6.28B | $6.52B | $6.73B | · | $7.52B | |
| Other Non-current Assets | $1.37B | $866M | $528M | $593M | $1.11B | $1.24B | $593M | $617M | $1.09B | $823M | · | $560M | $2.87B | $2.78B | · | $2.60B | |
| Total Assets | $83.01B | $81.17B | $76.75B | $82.09B | $86.39B | $87.04B | $82.44B | $82.35B | $83.14B | $82.62B | · | $84.38B | $82.85B | $82.98B | · | $81.17B | |
| Accounts Payable | $17.96B | $16.83B | $13.77B | $16.88B | $13.52B | $13.95B | $13.17B | $13.34B | $12.23B | $12.13B | · | $15.08B | $9.87B | $10.78B | · | $9.99B | |
| Current Liabilities | $40.76B | $40.05B | $36.70B | $40.63B | $36.79B | $37.14B | $34.26B | $34.06B | $32.73B | $32.78B | · | $36.85B | $31.31B | $32.86B | · | $31.33B | |
| Capital Leases | · | · | $615M | · | · | · | $738M | · | · | · | · | $936M | $3.17B | $3.14B | · | $3.04B | |
| Deferred Tax | $756M | $744M | $833M | $810M | $651M | $708M | $684M | $769M | $665M | $734M | · | $577M | $495M | $522M | · | $480M | |
| Other Non-current Liabilities | $2.81B | $2.55B | $1.81B | $2.05B | $3.90B | $2.87B | $2.57B | $2.62B | $4.77B | $4.16B | · | $3.65B | $7.37B | $6.19B | · | $5.68B | |
| Total Liabilities | $60.35B | $59.65B | $56.69B | $61.03B | $58.89B | $59.02B | $55.94B | $54.94B | $55.68B | $55.56B | · | $58.97B | $57.07B | $57.80B | · | $55.57B | |
| Long-term Debt | $16.11B | $16.37B | $17.49B | $17.58B | $17.58B | $18.32B | $18.53B | $17.61B | $17.63B | $18.00B | · | $18.00B | $18.01B | $18.32B | · | $18.33B | |
| Total Debt | $16.11B | $16.37B | · | $17.58B | $17.58B | $18.32B | · | $17.61B | $17.63B | $18.00B | · | $18.00B | $18.01B | $18.32B | · | $18.33B | |
| Common Stock | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | · | $1M | $1M | $1M | · | $1M | |
| Retained Earnings | $11.31B | $10.21B | $8.67B | $9.78B | $16.41B | $16.66B | $15.35B | $15.06B | $14.35B | $13.21B | · | $12.00B | $11.53B | $10.47B | · | $9.55B | |
| Treasury Stock | $9.44B | $9.44B | $9.44B | $9.44B | $9.44B | $9.04B | $9.00B | $8.05B | $6.82B | $6.01B | · | $5.83B | $5.04B | $4.64B | · | $2.56B | |
| AOCI | $-194M | $-171M | $-58M | $-100M | $-231M | $-337M | $-504M | $-226M | $-646M | $-630M | · | $-1.12B | $-998M | $-915M | · | $-1.39B | |
| Stockholders' Equity | $22.56B | $21.43B | $19.95B | $20.95B | $27.41B | $27.92B | $26.41B | $27.31B | $27.35B | $26.96B | · | $25.30B | $25.67B | $25.04B | · | $25.38B | |
| Liabilities + Equity | $83.01B | $81.17B | $76.75B | $82.09B | $86.39B | $87.04B | $82.44B | $82.35B | $83.14B | $82.62B | · | $84.38B | $82.85B | $82.98B | · | $81.17B | |
| Shares Outstanding | 493,987,000 | 493,771,000 | 491,757,000 | 491,414,000 | 491,128,000 | 497,518,000 | 495,907,000 | 510,078,000 | 526,001,000 | 536,383,000 | 615,291,000 | 534,596,000 | 546,003,000 | 551,714,000 | 607,847,000 | 570,091,000 |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $300M | $300M | $329M | $317M | $315M | $314M | $314M | $313M | $306M | $308M | $315M | $328M | $304M | $325M | $351M | $292M | |
| Stock-based Comp | $59M | $67M | $58M | $52M | $35M | $59M | $31M | $49M | $62M | $70M | $49M | $50M | $56M | $61M | $54M | $51M | |
| Deferred Tax | $19M | $-53M | $-73M | $129M | $-89M | $-27M | $-1M | $-26M | $-64M | $104M | $-92M | $174M | $-1M | $-159M | $51M | $-265M | |
| Amort. of Intangibles | $161M | $166M | $169M | $170M | $173M | $173M | $173M | $173M | $173M | $173M | $176M | $180M | $179M | $183M | $208M | $211M | |
| Operating Cash Flow | $3.59B | $4.37B | $437M | $1.36B | $1.78B | $1.51B | $-587M | $-978M | $2.17B | $-456M | $217M | $1.02B | $2.55B | $4.27B | $-1.58B | $3.33B | |
| CapEx | $174M | $200M | $213M | $211M | $208M | $135M | $154M | $153M | $186M | $151M | $223M | $136M | $215M | $225M | $233M | $247M | |
| Investing Cash Flow | $-353M | $89M | $660M | $1.24B | $-899M | $-529M | $102M | $-839M | $-1.17B | $852M | $-949M | $435M | $-424M | $-253M | $221M | $3M | |
| Debt Issued | $0 | $0 | $0 | $0 | $0 | $750M | $950M | $0 | $0 | $350M | $165M | $889M | $994M | $287M | $3M | $26M | |
| Net Debt Issued | · | $-1.05B | · | · | · | $-208M | · | · | · | $163M | · | · | · | $287M | · | · | |
| Stock Issued | $8M | $10M | $8M | $11M | $8M | $10M | $9M | $12M | $11M | $14M | $12M | $11M | $21M | $12M | $8M | $24M | |
| Stock Repurchased | $4M | $29M | $2M | $0 | $432M | $41M | $943M | $1.23B | $803M | $151M | $31M | $774M | $405M | $423M | $1.43B | $1.24B | |
| Net Stock Activity | · | $-19M | · | · | · | $-31M | · | · | · | $-137M | · | · | · | $-423M | · | · | |
| Financing Cash Flow | $-259M | $-1.06B | $-187M | $-10M | $-1.17B | $-250M | $-13M | $-1.25B | $-1.17B | $23M | $-201M | $-524M | $-750M | $-183M | $-1.73B | $-1.48B | |
| Net Change in Cash | $2.98B | $3.39B | $910M | $2.59B | $-288M | $731M | $-497M | $-3.06B | $-162M | $425M | $-984M | $958M | $1.36B | $3.83B | $-3.06B | $1.83B | |
| Taxes Paid | $-206M | $-19M | $-92M | $36M | $497M | $7M | $181M | $211M | $538M | $13M | $128M | $167M | $581M | $11M | $750M | $37M | |
| Free Cash Flow | · | $4.17B | · | · | · | $1.38B | · | · | · | $-607M | · | · | · | $4.04B | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $-747M | · | · | · | $3.90B | · | · |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 8.6% | 11.3% | · | 6.7% | 6.2% | 11.3% | · | 9.5% | 11.4% | 11.7% | · | 12.2% | 12.3% | 11.9% | · | · | |
| Operating Margin | 2.2% | 3.7% | · | -14.0% | -0.94% | 3.3% | · | 1.6% | 3.1% | 2.7% | · | 1.9% | 3.1% | 3.1% | · | 1.3% | |
| Net Margin | 2.0% | 3.1% | · | -13.3% | -0.52% | 2.8% | · | 1.7% | 2.9% | 2.9% | · | 1.2% | 2.8% | 2.9% | · | 2.1% | |
| Pretax Margin | 2.8% | 4.2% | · | -13.4% | -0.53% | 3.8% | · | 2.2% | 3.8% | 3.6% | · | 2.0% | 3.8% | 3.6% | · | 2.8% | |
| EBITDA Margin | 2.2% | 3.7% | · | -14.0% | -0.94% | 3.3% | · | 1.6% | 3.1% | 2.7% | · | 1.9% | 3.1% | 3.1% | · | 1.3% | |
| ROA | 1.3% | 1.8% | · | -8.1% | -0.30% | 1.6% | · | 0.86% | 1.4% | 1.4% | · | 0.57% | 1.3% | 1.4% | · | 0.93% | |
| ROE | 4.4% | 6.2% | · | -27.5% | -0.92% | 4.8% | · | 2.7% | 4.3% | 4.5% | · | 1.8% | 4.1% | 4.3% | · | 2.9% | |
| ROIC | 2.3% | 3.6% | · | -17.9% | -1.0% | 2.5% | · | 1.1% | 2.1% | 1.9% | · | 1.1% | 2.0% | 2.3% | · | 0.80% |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.1 | 1.1 | · | 1.1 | 1.1 | 1.1 | · | 1.1 | 1.2 | 1.2 | · | 1.1 | 1.1 | 1.1 | · | 1.1 | |
| Quick Ratio | 0.7 | 0.6 | · | 0.5 | 0.5 | 0.5 | · | 0.5 | 0.6 | 0.6 | · | 0.6 | 0.6 | 0.5 | · | 0.5 | |
| Debt / Equity | 0.7 | 0.8 | · | 0.8 | 0.6 | 0.7 | · | 0.6 | 0.6 | 0.7 | · | 0.7 | 0.7 | 0.7 | · | 0.7 | |
| LT Debt / Equity | 0.7 | 0.8 | · | 0.8 | 0.6 | 0.7 | · | 0.6 | 0.6 | 0.7 | · | 0.7 | 0.7 | 0.7 | · | 0.7 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 6.2 | · | 4.1 | 6.5 | 6.8 | · | 2.8 |
Effizienz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.6 | 0.6 | · | 0.6 | 0.6 | 0.5 | · | 0.5 | 0.5 | 0.5 | · | 0.5 | 0.5 | 0.5 | · | 0.5 |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $45.67 | $43.39 | · | $42.63 | $55.80 | $56.11 | · | $53.53 | $52.00 | $50.26 | · | $47.32 | $47.02 | $45.39 | · | $44.52 | |
| Revenue / Share | $107.67 | $100.78 | · | $101.17 | $98.76 | $93.58 | · | $80.27 | $75.06 | $75.10 | · | $70.28 | $68.34 | $70.22 | · | $61.77 | |
| Cash Flow / Share | · | $8.81 | · | · | · | $3.03 | · | · | · | $-0.85 | · | · | · | $7.71 | · | · | |
| Cash / Share | $48.89 | $43.06 | · | $34.71 | $29.55 | $29.78 | · | $28.58 | $33.47 | $32.78 | · | $34.03 | $31.45 | $28.73 | · | $26.29 | |
| EPS (TTM) | $-10.35 | $-13.05 | · | $-10.75 | $4.11 | $6.78 | · | $5.80 | $5.31 | $5.07 | · | $4.48 | $4.88 | $2.67 | · | $3.44 |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $202.94B | $198.10B | · | $185.86B | $178.19B | $169.28B | · | $161.73B | $157.75B | $155.52B | · | $150.10B | $147.92B | $146.25B | · | $141.55B | |
| Net Income TTM | $-5.10B | $-6.44B | · | $-5.29B | $2.05B | $3.45B | · | $3.07B | $2.82B | $2.73B | · | $2.44B | $2.71B | $1.48B | · | $2.01B | |
| Market Cap | $31.71B | $16.17B | · | $17.53B | $26.66B | $30.20B | · | $38.40B | $34.87B | $42.10B | · | $36.82B | $36.83B | $34.87B | · | $44.36B | |
| Enterprise Value | $20.76B | $8.80B | · | $15.88B | $26.95B | $31.24B | · | $38.43B | $32.29B | $40.43B | · | $34.39B | $35.45B | $35.21B | · | $45.51B | |
| P/E | -6.2 | -2.5 | · | -3.3 | 13.2 | 9.0 | · | 13.0 | 12.5 | 15.5 | · | 15.4 | 13.8 | 23.7 | · | 22.6 | |
| P/S | 0.2 | 0.1 | · | 0.1 | 0.1 | 0.2 | · | 0.2 | 0.2 | 0.3 | · | 0.2 | 0.2 | 0.2 | · | 0.3 | |
| P/B | 1.4 | 0.8 | · | 0.8 | 1.0 | 1.1 | · | 1.4 | 1.3 | 1.6 | · | 1.5 | 1.4 | 1.4 | · | 1.7 | |
| P / Tangible Book | 4.2 | 2.6 | · | 3.3 | 5.5 | 5.9 | · | 9.2 | 8.6 | 12.1 | · | 25.2 | 84.7 | · | · | · | |
| P / Cash Flow | · | 3.7 | · | · | · | 20.0 | · | · | · | -92.3 | · | · | · | 8.2 | · | · | |
| EV / Revenue | 0.1 | 0.0 | · | 0.1 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.3 | · | 0.2 | 0.2 | 0.2 | · | 0.3 | |
| Earnings Yield | -16.1% | -39.9% | · | -30.1% | 7.6% | 11.2% | · | 7.7% | 8.0% | 6.5% | · | 6.5% | 7.2% | 4.2% | · | 4.4% |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Umsatz | $194.78B | $163.07B | $154.00B | $144.55B | $125.98B |
| Bruttogewinnmarge % | 7.3% | 10.5% | 11.5% | · | · |
| Betriebsgewinnmarge % | -3.9% | 1.9% | 1.9% | 0.91% | 1.4% |
| Nettoergebnis | $-6.67B | $3.31B | $2.70B | $1.20B | $1.35B |
| Verwässerte EPS | $-13.53 | $6.31 | $4.95 | $2.07 | $2.28 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital | 0.9 | 0.7 | 0.7 | 0.7 | 0.7 |
| Liquiditätsgrad | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 |
| Quick Ratio | 0.6 | 0.5 | 0.5 | 0.5 | 0.6 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Freier Cashflow | $4.32B | $-490M | $7.25B | $5.26B | $3.29B |
Institutionelle Eigentümer (13F) 1.111 Einreicher · $33.3B gesamt · Stand 30. September 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 231 (+108 vs. Vorquartal) | 76 (-54 vs. Vorquartal) | 355 (+53 vs. Vorquartal) | 345 (-22 vs. Vorquartal) | +22.9M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| BlackRock, Inc. | $2.660.421.666 | 41.446.046 | 7,99% | Aktien |
| VANGUARD GROUP INC | $2.344.675.686 | 56.978.753 | 7,04% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $2.020.581.807 | 31.478.140 | 6,07% | Aktien |
| AQR CAPITAL MANAGEMENT LLC | $1.840.885.817 | 28.678.701 | 5,53% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1.434.820.070 | 22.352.704 | 4,31% | Aktien |
| STATE STREET CORP | $1.409.957.100 | 21.965.370 | 4,23% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $854.004.542 | 13.309.729 | 2,56% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $853.804.990 | 13.301.215 | 2,56% | Aktien |
| AMERIPRISE FINANCIAL INC | $798.163.652 | 12.419.397 | 2,40% | Aktien |
| Invesco Ltd. | $717.634.165 | 11.179.844 | 2,16% | Aktien |
| HARRIS ASSOCIATES L P | $714.090.642 | 11.124.640 | 2,14% | Aktien |
| MORGAN STANLEY | $645.218.827 | 10.051.700 | 1,94% | Aktien |
| NORGES BANK | $491.166.346 | 7.651.758 | 1,48% | Aktien |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $478.360.377 | 7.452.257 | 1,44% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $447.787.001 | 6.975.962 | 1,34% | Aktien |
| GOLDMAN SACHS GROUP INC | $408.195.518 | 6.359.176 | 1,23% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $407.480.559 | 6.348.038 | 1,22% | Aktien |
| VICTORY CAPITAL MANAGEMENT INC | $366.680.625 | 5.712.426 | 1,10% | Aktien |
| D. E. Shaw & Co., Inc. | $334.649.558 | 5.213.422 | 1,00% | Aktien |
| NORTHERN TRUST CORP | $316.495.405 | 4.930.603 | 0,95% | Aktien |
| DEERFIELD MANAGEMENT COMPANY, L.P. | $314.595.190 | 4.901.000 | 0,94% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $290.158.057 | 4.520.300 | 0,87% | Kaufoption |
| BANK OF AMERICA CORP /DE/ | $285.713.156 | 4.451.054 | 0,86% | Aktien |
| DEUTSCHE BANK AG\ | $257.278.913 | 4.008.084 | 0,77% | Aktien |
| JANE STREET GROUP, LLC | $245.125.049 | 3.818.742 | 0,74% | Aktien |
| Legal & General Group Plc | $244.462.540 | 3.808.421 | 0,73% | Aktien |
| Assenagon Asset Management S.A. | $238.531.902 | 3.716.029 | 0,72% | Aktien |
| EARNEST PARTNERS LLC | $227.030.787 | 3.536.856 | 0,68% | Aktien |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $219.279.973 | 3.416.108 | 0,66% | Aktien |
| PANAGORA ASSET MANAGEMENT INC | $197.821.063 | 3.081.805 | 0,59% | Aktien |
| 8 KNOTS MANAGEMENT, LLC | $193.662.188 | 4.706.250 | 0,58% | Aktien |
| Amundi | $193.109.645 | 3.008.407 | 0,58% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $192.239.858 | 2.994.644 | 0,58% | Aktien |
| Man Group plc | $179.419.908 | 2.795.138 | 0,54% | Aktien |
| Robeco Institutional Asset Management B.V. | $176.439.634 | 2.748.709 | 0,53% | Aktien |
| AMERICAN CENTURY COMPANIES INC | $170.815.325 | 2.661.089 | 0,51% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $170.810.874 | 2.661.020 | 0,51% | Aktien |
| FMR LLC | $168.737.981 | 2.628.727 | 0,51% | Aktien |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | $164.395.918 | 2.561.083 | 0,49% | Aktien |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $160.731.497 | 4.909.331 | 0,48% | Aktien |
| Bank of New York Mellon Corp | $159.011.486 | 2.477.200 | 0,48% | Aktien |
| LYRICAL ASSET MANAGEMENT LP | $157.262.740 | 2.449.957 | 0,47% | Aktien |
| JPMORGAN CHASE & CO | $151.762.514 | 2.351.448 | 0,46% | Aktien |
| JANE STREET GROUP, LLC | $150.243.114 | 2.340.600 | 0,45% | Kaufoption |
| RENAISSANCE TECHNOLOGIES LLC | $140.730.926 | 2.192.412 | 0,42% | Aktien |
| Russell Investments Group, Ltd. | $138.296.549 | 2.151.926 | 0,42% | Aktien |
| Politan Capital Management LP | $137.059.130 | 2.135.210 | 0,41% | Aktien |
| CITADEL ADVISORS LLC | $135.787.526 | 2.115.400 | 0,41% | Kaufoption |
| Qube Research & Technologies Ltd | $131.408.741 | 2.047.184 | 0,39% | Aktien |
| Quantinno Capital Management LP | $126.343.727 | 1.968.277 | 0,38% | Aktien |
Unternehmensinsider 78 Insider · 49 Führungskräfte · 30 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Sarah London | Chief Executive Officer | 15. März 2026 F | 1.188.831 | 0 | 0 | $0 |
| David P Thomas | CEO, Markets and Medicaid | 15. Dezember 2023 F | 132.941 | 0 | 0 | $0 |
| NEIDORFF MICHAEL F | Chairman & CEO | 15. Dezember 2021 A | 6.517.610 | 0 | 0 | $0 |
| Andrew Lynn Asher | Chief Financial Officer | 15. März 2026 F | 747.989 | 0 | 0 | $0 |
| William Scheffel | Exec VP, CFO & Treasurer | 1. März 2016 F | 138.362 | 0 | 0 | $0 |
| Michael A Carson | Group President, Medicare&Spec | 29. Mai 2026 I | · | 0 | 0 | $0 |
| Kenneth J Fasola | President | 4. Juli 2024 F | 286.066 | 0 | 0 | $0 |
| Susan Raye Smith | Chief Operating Officer | 15. Juni 2026 F | 212.237 | 0 | 0 | $0 |
| James E Murray | EVP, Chief Operating Officer | 23. Juni 2023 A | 202.853 | 0 | 0 | $0 |
| Theodore J Pienkos | Corporate Controller & CAO | 15. September 2026 F | 28.751 | 0 | 0 | $0 |
| Christopher Koster | Secretary & General Counsel | 26. August 2026 S | 248.854 | 0 | 2 | $-6.891.182 |
| Tanya M Mcnally | Chief People Officer | 15. April 2026 F | 127.258 | 0 | 0 | $0 |
| Katie Casso | Corporate Controller & CAO | 15. März 2026 F | 109.776 | 0 | 0 | $0 |
| Colin A Toney | EVP, Mergers & Acquisitions | 16. September 2022 A | 52.123 | 0 | 0 | $0 |
| Mark J Brooks | EVP, Chief Information Officer | 16. September 2022 A | 153.755 | 0 | 0 | $0 |
| Shannon Bagley | EVP, Chief Admin. Officer | 16. August 2022 F | 116.705 | 0 | 0 | $0 |
| Brandy Burkhalter | EVP | 24. März 2022 F | 350.475 | 0 | 0 | $0 |
| Jesse N Hunter | EVP, M&A & Chief Strategy Ofcr | 11. Juni 2021 S | 411.792 | 0 | 0 | $0 |
| Jeffrey A. Schwaneke | EVP, HealthCare Enterprises | 7. Mai 2021 S | 454.549 | 0 | 0 | $0 |
| Christopher R Isaak | SVP, Corporate Controller, CAO | 15. Dezember 2020 F | 13.630 | 0 | 0 | $0 |
| Keith H Williamson | EVP, Secr. & General Counsel | 4. Februar 2020 F | 174.049 | 0 | 0 | $0 |
| Christopher D Bowers | EVP, Markets | 22. Juli 2019 A | 131.492 | 0 | 0 | $0 |
| Cynthia J Brinkley | EVP, Chief Admin/Markets Offcr | 5. Februar 2019 F | 300.582 | 0 | 0 | $0 |
| Kenneth Rone Baldwin | EVP, Markets | 15. Dezember 2016 F | 92.712 | 0 | 0 | $0 |
| Carol Goldman | Exec VP Chief Admin Officer | 15. Dezember 2016 F | 70.876 | 0 | 0 | $0 |
| Donald G Imholz | EVP, Operations and CIO | 11. Dezember 2015 G | 151.599 | 0 | 0 | $0 |
| David C Minifie | CMO, EVP Corporate Strategy | 3. Februar 2015 F | 24.031 | 0 | 0 | $0 |
| Robert T Hitchcock | EVP Health Plans | 3. Februar 2015 F | 26.415 | 0 | 0 | $0 |
| Edmund E Kroll | SVP Fin & Investor Relations | 3. Februar 2015 F | 46.279 | 0 | 0 | $0 |
| HARROLD JASON M | EVP, Specialty Comp. Bus. Unit | 3. Februar 2015 F | 44.329 | 0 | 0 | $0 |
| Karen Bedell | SVP Business Liaison | 14. Dezember 2012 F | 46.819 | 0 | 0 | $0 |
| Mary V Mason | SVP & Chief Medical Officer | 14. Dezember 2012 F | 38.974 | 0 | 0 | $0 |
| Mark W Eggert | Executive VP, Health Plans | 14. Februar 2012 M | 103.712 | 0 | 0 | $0 |
| Antonette Simonetti | SVP, Public Affairs | 14. Dezember 2010 F | 13.377 | 0 | 0 | $0 |
| Frederick J Manning | Executive Vice President | 14. Dezember 2010 F | 20.579 | 0 | 0 | $0 |
| Cary Hobbs | SVP, Bus Mgmt & Integration | 16. Dezember 2009 M | 20.768 | 0 | 0 | $0 |
| Eric Slusser | Executive VP of Internat'l Dev | 16. Oktober 2009 A | 51.754 | 0 | 0 | $0 |
| Patti Darnley | Sr. VP of Operations | 14. Dezember 2007 A | 14.188 | 0 | 0 | $0 |
| Marie J Glancy | SVP, Oper Svcs & Reg Affairs | 14. Dezember 2007 A | 12.362 | 0 | 0 | $0 |
| Per J Brodin | SVP, Chief Acctg Officer | 12. Dezember 2007 A | 13.337 | 0 | 0 | $0 |
| Glendon A Schuster | Senior VP and CIO | 12. Dezember 2006 A | · | 0 | 0 | $0 |
| Lisa M Wilson | Sr. VP Investor Relations | 12. Dezember 2006 A | 18.400 | 0 | 0 | $0 |
| Karey L Witty | SVP, Health Plan Business Unit | 12. Dezember 2006 A | 57.500 | 0 | 0 | $0 |
| Joseph P Drozda JR | Sr. VP & Chief Medical Officer | 12. Dezember 2006 A | 32.181 | 0 | 0 | $0 |
| James D Donovan JR | Senior VP Health Plans | 13. Dezember 2005 A | 3.219 | 0 | 0 | $0 |
| Brian G Spanel | Sr Vice President, Development | 24. Juni 2005 M | 186.446 | 0 | 0 | $0 |
| Dan Paquin | Sr. VP New Plan Implementation | 10. Februar 2005 M | 0 | 0 | 0 | $0 |
| John Tadich | Senior VP, Specialty Companies | 1. Dezember 2004 M | 0 | 0 | 0 | $0 |
| Catherine M Halverson | Senior VP Business Development | 16. Januar 2004 | 0 | 0 | 0 | $0 |
| Lauren M Tyler | Direktor | 30. September 2026 A | 3.698 | 0 | 0 | $0 |
| Kenneth Tanji | Direktor | 30. September 2026 A | 13.093 | 0 | 0 | $0 |
| Theodore R. Samuels II | Direktor | 30. September 2026 A | 25.796 | 0 | 0 | $0 |
| Frederick H Eppinger | Direktor | 30. September 2026 A | 370.402 | 0 | 0 | $0 |
| COUGHLIN CHRISTOPHER J | Direktor | 30. September 2026 A | 19.294 | 0 | 0 | $0 |
| Paul J Diaz | Direktor | 28. Juli 2026 A | 2.771 | 0 | 0 | $0 |
| Kenneth A Burdick | Direktor | 10. Juni 2026 S | 197.086 | 0 | 3 | $-7.739.601 |
| Jessica L. Blume | Direktor | 12. Mai 2026 A | 32.357 | 0 | 0 | $0 |
| James H Dallas | Direktor | 12. Mai 2026 A | 47.874 | 0 | 0 | $0 |
| Monte E Ford | Direktor | 12. Mai 2026 A | 14.827 | 0 | 0 | $0 |
| Wayne S Deveydt | Direktor | 30. Juni 2025 A | 19.523 | 0 | 0 | $0 |
| Thomas Greco | Direktor | 13. Mai 2025 A | 22.888 | 0 | 0 | $0 |
| Lori Jean Robinson | Direktor | 14. Mai 2024 A | 14.371 | 0 | 0 | $0 |
| William L Trubeck | Direktor | 31. März 2023 A | 97.147 | 0 | 0 | $0 |
| Richard A Gephardt | Direktor | 8. Juli 2022 S | 22.560 | 0 | 0 | $0 |
| Orlando Ayala | Direktor | 26. April 2022 A | 77.202 | 0 | 0 | $0 |
| Leslie V Norwalk | Direktor | 31. März 2022 A | 1.481 | 0 | 0 | $0 |
| Tommy G Thompson | Direktor | 31. Dezember 2021 A | 227.334 | 0 | 0 | $0 |
| Robert K Ditmore | Direktor | 31. Dezember 2021 A | 666.486 | 0 | 0 | $0 |
| ROBERTS JOHN R | Direktor | 31. Dezember 2021 A | 194.891 | 0 | 0 | $0 |
| David L Steward | Direktor | 30. September 2021 A | 219.294 | 0 | 0 | $0 |
| Vicki B Escarra | Direktor | 26. April 2016 A | 15.035 | 0 | 0 | $0 |
| JOSEPH PAMELA A | Direktor | 31. März 2016 A | 140.534 | 0 | 0 | $0 |
| Steve Bartlett | Direktor | 31. März 2010 A | 59.184 | 0 | 0 | $0 |
| Richard P Wiederhold | Direktor | 26. April 2005 A | 104.415 | 0 | 0 | $0 |
| Samuel E Bradt | Direktor | 25. Februar 2005 M | 106.460 | 0 | 0 | $0 |
| Claire W Johnson | Direktor | 4. Mai 2004 M | 350.834 | 0 | 0 | $0 |
| Edward L Cahill | Direktor | 22. Dezember 2003 M | · | 0 | 0 | $0 |
| Brent D Layton | · | 10. Dezember 2022 F | 562.853 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 140 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| IHF · iShares Trust | 4,22% | 845.566 SH | 11. September 2026 | Täglich |
| ADPV · Series Portfolios Trust | 3,63% | 104.120 NS | 31. Juli 2026 | N-PORT |
| RPV · Invesco Exchange-Traded Fund Trust | 2,66% | 700.946 SH | 5. Oktober 2026 | Täglich |
| CAMX · ADVISORS' INNER CIRCLE FUND | 2,36% | 25.865 NS | 31. Juli 2026 | N-PORT |
| FXH · First Trust Exchange-Traded AlphaDE… | 2,20% | 369.699 NS | 31. Juli 2026 | N-PORT |
| SRHQ · Elevation Series Trust | 2,09% | 71.389 NS | 31. Juli 2026 | N-PORT |
| UPGD · Invesco Exchange-Traded Fund Trust | 2,02% | 37.043 SH | 5. Oktober 2026 | Täglich |
| SMRI · EA Series Trust | 1,78% | 183.865 NS | 31. Juli 2026 | N-PORT |
| EPMB · Harbor ETF Trust | 1,72% | 1.264 NS | 31. Juli 2026 | N-PORT |
| AMOM · Exchange Listed Funds Trust | 1,65% | 6.344 NS | 31. Juli 2026 | N-PORT |
| RSPH · Invesco Exchange-Traded Fund Trust | 1,62% | 225.432 SH | 5. Oktober 2026 | Täglich |
| JMID · Janus Detroit Street Trust | 1,57% | 5.970 NS | 31. Juli 2026 | N-PORT |
| EPMV · Harbor ETF Trust | 1,54% | 1.157 NS | 31. Juli 2026 | N-PORT |
| EPSB · Harbor ETF Trust | 1,31% | 1.011 NS | 31. Juli 2026 | N-PORT |
| JDOC · J.P. Morgan Exchange-Traded Fund Tr… | 1,19% | 1.740 NS | 31. Juli 2026 | N-PORT |
| RILA · Spinnaker ETF Series | 1,03% | 6.956 NS | 31. Juli 2026 | N-PORT |
| BSCU · Invesco Exchange-Traded Self-Indexe… | 1,03% | 31.313.000 | 5. Oktober 2026 | Täglich |
| RWL · Invesco Exchange-Traded Fund Trust … | 1,02% | 1.580.927 SH | 5. Oktober 2026 | Täglich |
| NULV · Nushares ETF Trust | 0,79% | 280.661 NS | 31. Juli 2026 | N-PORT |
| WLDR · Two Roads Shared Trust | 0,77% | 11.314 NS | 31. Juli 2026 | N-PORT |
| PALC · Pacer Funds Trust | 0,74% | 25.112 NS | 31. Juli 2026 | N-PORT |
| LSEQ · Harbor ETF Trust | 0,74% | 1.827 NS | 31. Juli 2026 | N-PORT |
| BSCT · Invesco Exchange-Traded Self-Indexe… | 0,72% | 22.217.000 | 5. Oktober 2026 | Täglich |
| PDP · Invesco Exchange-Traded Fund Trust | 0,71% | 169.193 SH | 5. Oktober 2026 | Täglich |
| FVAL · FIDELITY COVINGTON TRUST | 0,70% | 149.479 NS | 31. Juli 2026 | N-PORT |
| QIDX · Spinnaker ETF Series | 0,59% | 3.713 NS | 31. Juli 2026 | N-PORT |
| IYH · iShares Trust | 0,52% | 288.766 SH | 11. September 2026 | Täglich |
| VLUE · iShares Trust | 0,51% | 746.350 SH | 11. September 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,47% | 1.478.248 SH | 19. August 2026 | Täglich |
| USMV · iShares Trust | 0,46% | 1.681.809 SH | 11. September 2026 | Täglich |
| BSCS · Invesco Exchange-Traded Self-Indexe… | 0,46% | 17.129.000 | 5. Oktober 2026 | Täglich |
| FHLC · FIDELITY COVINGTON TRUST | 0,44% | 233.934 NS | 31. Juli 2026 | N-PORT |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0,42% | 64.238 SH | 5. Oktober 2026 | Täglich |
| ESMV · iShares Trust | 0,40% | 471 SH | 11. September 2026 | Täglich |
| IXJ · iShares Trust | 0,39% | 246.114 SH | 11. September 2026 | Täglich |
| REVS · Columbia ETF Trust I | 0,36% | 19.335 NS | 31. Juli 2026 | N-PORT |
| VBR · VANGUARD INDEX FUNDS | 0,34% | 3.594.629 SH | 19. August 2026 | Täglich |
| CURE · Direxion Shares ETF Trust | 0,33% | 9.231 NS | 31. Juli 2026 | N-PORT |
| VFVA · VANGUARD WELLINGTON FUND | 0,32% | 41.665 SH | 19. August 2026 | Täglich |
| FTLS · First Trust Exchange-Traded Fund III | 0,31% | 123.861 NS | 31. Juli 2026 | N-PORT |
| PRF · Invesco Exchange-Traded Fund Trust | 0,30% | 473.830 SH | 5. Oktober 2026 | Täglich |
| IWS · iShares Trust | 0,29% | 676.448 SH | 11. September 2026 | Täglich |
| VOE · VANGUARD INDEX FUNDS | 0,27% | 1.586.002 SH | 19. August 2026 | Täglich |
| RECS · Columbia ETF Trust I | 0,25% | 238.673 NS | 31. Juli 2026 | N-PORT |
| VFMF · VANGUARD WELLINGTON FUND | 0,24% | 26.528 SH | 19. August 2026 | Täglich |
| IWR · iShares Trust | 0,24% | 2.022.616 SH | 11. September 2026 | Täglich |
| IMCG · iShares Trust | 0,23% | 140.912 SH | 11. September 2026 | Täglich |
| IMCB · iShares Trust | 0,23% | 57.854 SH | 11. September 2026 | Täglich |
| IMCV · iShares Trust | 0,22% | 39.003 SH | 11. September 2026 | Täglich |
| SIZE · iShares Trust | 0,21% | 13.786 SH | 11. September 2026 | Täglich |
| MTUM · iShares Trust | 0,21% | 767.210 SH | 11. September 2026 | Täglich |
| EUSA · iShares, Inc. | 0,21% | 60.306 SH | 11. September 2026 | Täglich |
| RSP · Invesco Exchange-Traded Fund Trust | 0,20% | 3.039.651 SH | 5. Oktober 2026 | Täglich |
| SPMO · Invesco Exchange-Traded Fund Trust … | 0,20% | 729.156 SH | 5. Oktober 2026 | Täglich |
| ACWV · iShares, Inc. | 0,19% | 97.765 SH | 11. September 2026 | Täglich |
| VB · VANGUARD INDEX FUNDS | 0,19% | 5.662.592 SH | 19. August 2026 | Täglich |
| QLC · FlexShares Trust | 0,18% | 29.568 NS | 31. Juli 2026 | N-PORT |
| XOEF · iShares Trust | 0,17% | 589 SH | 11. September 2026 | Täglich |
| JVAL · J.P. Morgan Exchange-Traded Fund Tr… | 0,17% | 23.098 NS | 31. Juli 2026 | N-PORT |
| FBUF · Fidelity Greenwood Street Trust | 0,16% | 625 NS | 31. Juli 2026 | N-PORT |
| FYEE · Fidelity Greenwood Street Trust | 0,16% | 5.706 NS | 31. Juli 2026 | N-PORT |
| INFO · Harbor ETF Trust | 0,15% | 20.500 NS | 31. Juli 2026 | N-PORT |
| VO · VANGUARD INDEX FUNDS | 0,15% | 5.350.449 SH | 19. August 2026 | Täglich |
| BSCR · Invesco Exchange-Traded Self-Indexe… | 0,13% | 5.970.000 | 5. Oktober 2026 | Täglich |
| LQAI · Exchange Listed Funds Trust | 0,13% | 47 NS | 31. Juli 2026 | N-PORT |
| EVUS · iShares Trust | 0,13% | 7.625 SH | 11. September 2026 | Täglich |
| FHEQ · Fidelity Greenwood Street Trust | 0,11% | 16.647 NS | 31. Juli 2026 | N-PORT |
| GARP · iShares Trust | 0,11% | 51.524 SH | 11. September 2026 | Täglich |
| IVE · iShares Trust | 0,10% | 778.556 SH | 11. September 2026 | Täglich |
| VEGN · ETF Series Solutions | 0,10% | 2.889 NS | 31. Juli 2026 | N-PORT |
| VOOV · VANGUARD ADMIRAL FUNDS | 0,10% | 107.912 SH | 19. August 2026 | Täglich |
| IUSV · iShares Trust | 0,10% | 411.368 SH | 11. September 2026 | Täglich |
| DSI · iShares Trust | 0,09% | 75.447 SH | 11. September 2026 | Täglich |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0,09% | 11.559 SH | 5. Oktober 2026 | Täglich |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0,08% | 273.939 SH | 19. August 2026 | Täglich |
| IWD · iShares Trust | 0,08% | 1.010.515 SH | 11. September 2026 | Täglich |
| OMFL · Invesco Exchange-Traded Self-Indexe… | 0,08% | 59.331 SH | 5. Oktober 2026 | Täglich |
| IWP · iShares Trust | 0,08% | 223.238 SH | 11. September 2026 | Täglich |
| GLBL · Pacer Funds Trust | 0,07% | 13 NS | 31. Juli 2026 | N-PORT |
| EGLE · Global X Funds | 0,07% | 24 NS | 31. Juli 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,07% | 5.972 NS | 31. Juli 2026 | N-PORT |
| DFUV · Dimensional ETF Trust | 0,07% | 165.653 NS | 31. Juli 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,06% | 22.307 NS | 31. Juli 2026 | N-PORT |
| VTV · VANGUARD INDEX FUNDS | 0,06% | 2.345.467 SH | 19. August 2026 | Täglich |
| TOPC · iShares Trust | 0,06% | 286 SH | 11. September 2026 | Täglich |
| QVML · Invesco Exchange-Traded Fund Trust … | 0,05% | 14.317 SH | 5. Oktober 2026 | Täglich |
| ILCG · iShares Trust | 0,05% | 24.930 SH | 11. September 2026 | Täglich |
| XVV · iShares Trust | 0,05% | 5.377 SH | 11. September 2026 | Täglich |
| ACVF · ETF Opportunities Trust | 0,05% | 1.243 NS | 31. Juli 2026 | N-PORT |
| VOO · VANGUARD INDEX FUNDS | 0,05% | 12.186.952 SH | 19. August 2026 | Täglich |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0,05% | 81.972 SH | 19. August 2026 | Täglich |
| ESGV · VANGUARD WORLD FUND | 0,05% | 111.541 SH | 19. August 2026 | Täglich |
| TOV · EA Series Trust | 0,05% | 2.108 NS | 31. Juli 2026 | N-PORT |
| XCLR · Global X Funds | 0,05% | 28 NS | 31. Juli 2026 | N-PORT |
| ILCB · iShares Trust | 0,05% | 9.566 SH | 11. September 2026 | Täglich |
| PBP · Invesco Exchange-Traded Fund Trust | 0,05% | 2.939 SH | 5. Oktober 2026 | Täglich |
| BBUS · J.P. Morgan Exchange-Traded Fund Tr… | 0,05% | 68.064 NS | 31. Juli 2026 | N-PORT |
| VOTE · TCW ETF Trust | 0,05% | 8.352 NS | 31. Juli 2026 | N-PORT |
| XYLG · Global X Funds | 0,05% | 487 NS | 31. Juli 2026 | N-PORT |
| IVV · iShares Trust | 0,05% | 5.909.725 SH | 11. September 2026 | Täglich |
| PBUS · Invesco Exchange-Traded Fund Trust … | 0,05% | 79.742 SH | 5. Oktober 2026 | Täglich |
| IWB · iShares Trust | 0,05% | 342.511 SH | 11. September 2026 | Täglich |
| XYLD · Global X Funds | 0,05% | 24.005 NS | 31. Juli 2026 | N-PORT |
| BKLC · BNY Mellon ETF Trust | 0,05% | 40.391 NS | 31. Juli 2026 | N-PORT |
| ILCV · iShares Trust | 0,05% | 9.229 SH | 11. September 2026 | Täglich |
| PTLC · Pacer Funds Trust | 0,05% | 23.629 NS | 31. Juli 2026 | N-PORT |
| IWV · iShares Trust | 0,04% | 137.718 SH | 11. September 2026 | Täglich |
| XTR · Global X Funds | 0,04% | 34 NS | 31. Juli 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,04% | 86.710 NS | 31. Juli 2026 | N-PORT |
| IYY · iShares Trust | 0,04% | 19.915 SH | 11. September 2026 | Täglich |
| XRMI · Global X Funds | 0,04% | 347 NS | 31. Juli 2026 | N-PORT |
| SPUU · Direxion Shares ETF Trust | 0,04% | 1.770 NS | 31. Juli 2026 | N-PORT |
| ITOT · iShares Trust | 0,04% | 606.832 SH | 11. September 2026 | Täglich |
| QDPL · Pacer Funds Trust | 0,04% | 11.305 NS | 31. Juli 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,04% | 137.476 NS | 31. Juli 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,04% | 15.677.747 SH | 19. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,04% | 41.539 SH | 19. August 2026 | Täglich |
| PHDG · Invesco Actively Managed Exchange-T… | 0,04% | 389 SH | 5. Oktober 2026 | Täglich |
| TOK · iShares Trust | 0,04% | 1.384 SH | 11. September 2026 | Täglich |
| TILT · FlexShares Trust | 0,04% | 12.956 NS | 31. Juli 2026 | N-PORT |
| HCMT · Direxion Shares ETF Trust | 0,04% | 3.263 NS | 31. Juli 2026 | N-PORT |
| DFLV · Dimensional ETF Trust | 0,04% | 39.039 NS | 31. Juli 2026 | N-PORT |
| URTH · iShares, Inc. | 0,04% | 44.755 SH | 11. September 2026 | Täglich |
| SPXL · Direxion Shares ETF Trust | 0,03% | 36.674 NS | 31. Juli 2026 | N-PORT |
| VOXP · Advisors Series Trust | 0,03% | 30 NS | 31. Juli 2026 | N-PORT |
| ACWI · iShares Trust | 0,03% | 155.744 SH | 11. September 2026 | Täglich |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,03% | 414.811 SH | 19. August 2026 | Täglich |
| DFAC · Dimensional ETF Trust | 0,03% | 212.958 NS | 31. Juli 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,03% | 14.746 NS | 31. Juli 2026 | N-PORT |
| VV · VANGUARD INDEX FUNDS | 0,02% | 288.031 SH | 19. August 2026 | Täglich |
| NEAR · iShares U.S. ETF Trust | 0,02% | 1.100.000 SH | 9. September 2026 | Täglich |
| VONG · VANGUARD SCOTTSDALE FUNDS | 0,01% | 62.968 SH | 19. August 2026 | Täglich |
| IWF · iShares Trust | 0,01% | 149.899 SH | 11. September 2026 | Täglich |
| PEVC · Pacer Funds Trust | 0,00% | 1 NS | 31. Juli 2026 | N-PORT |
| SLTY · Tidal Trust II | -4,57% | -13.500 NS | 31. Juli 2026 | N-PORT |
| VGHY · VANGUARD FIXED INCOME SECURITIES FU… | · | · | 15. Juli 2026 | Täglich |
| VCRB · VANGUARD MALVERN FUNDS | · | · | 15. Juli 2026 | Täglich |
| VPLS · VANGUARD MALVERN FUNDS | · | · | 15. Juli 2026 | Täglich |
| VSDB · VANGUARD MALVERN FUNDS | · | · | 15. Juli 2026 | Täglich |
| VGMS · VANGUARD MALVERN FUNDS | · | · | 15. Juli 2026 | Täglich |
CNC Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
12-Monats-Kursziel
18 Analysten · 2026-10-01Mittelwert-Ziel $71.78 +11,1%
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| CNC | $20.24B | -3.0 | 19.4% | -3.4% | -28.8% | 7.3% |
| UNH | $299.08B | 25.0 | 11.8% | 2.7% | 12.0% | · |
| ELV | $77.37B | 13.9 | 12.5% | 2.8% | 13.3% | · |
| HUM | $50.90B | 26.0 | 10.1% | 0.92% | 7.0% | · |
| MOH | $8.85B | 19.5 | 11.8% | 1.0% | 10.9% | · |
| HQY | $7.12B | 34.0 | 9.5% | 16.4% | 10.1% | 69.5% |
| CLOV | · | -5.1 | 40.3% | -4.5% | -26.2% | · |
| PGNY | $2.14B | 39.5 | 10.4% | 4.5% | 11.3% | 23.6% |
| ALHC | $4.03B | · | 46.1% | -0.02% | -0.52% | · |
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.